Please login to the form below

Outsourcing in Clinical Trials 2020 Virtual Conference

We recently had the pleasure of sponsoring and attending the Outsourcing in Clinical Trials (OCT) virtual conference. Although we would have loved to have met everyone in person, it was great to listen to those who share our passions and values and chat with everyone throughout the day. Read on for a low down of the talks that resonated with the team at COUCH Health the most.

If you’ve read our content before or have explored Demand Diversity, you’ll know how passionate we are about doing our bit to tackle the lack of diversity in clinical trials. Meghan McKenzie, Genentech highlighted that disease pattern, clinical presentation and therapeutic response can vary dramatically with ethnicity and ancestral background. This wasn’t news to us, but it was interesting to see these facts about the potentially underrepresented patients of the future:

  • By 2040, over half of US people living with Alzheimer’s disease will be black or Hispanic
  • By 2045, breast cancer in the US will increase by 72% in black people, 89% in Hispanic people and 120% in API
  • By 2050, Alzheimer’s disease cases in China will account for half of all global cases

It was great to see that Genentech is trying to act based on insights and challenges across different stakeholders. There’s an assumption among some site staff that patients of certain ethnicities aren’t willing or able and therefore aren’t asked to take part, so Genentech is introducing processes and training to ensure all potentially eligible patients are asked. Alongside this, a lot of traditional sites don’t have access to diverse patients or experience recruiting, so it was suggested to use target trial demographic and site mapping to identify sites with a diverse catchment area. While this is all (finally!) a step in the right direction, we were left wondering – how relevant are some of these actions while trust and awareness are so low among certain ethnic communities? While patient education and outreach were touched on, we strongly believe it needs to be at the forefront of any ethnic diversity strategy.

Using blockchain in clinical trials

If you haven’t come across blockchain technology, it’s essentially a way digital information (the block) can be stored in a public database (the chain). In this session by Frank Leu, CEO of Novapeutics, we were reminded that discovering and developing safe, effective drugs is a challenging and expensive process, which involves sophisticated technology and lots of different stakeholders. And with this in mind, we need effective tools that enhance the collaboration of sharing data. Blockchain is already being used to decentralise data elsewhere, and within the clinical trial space, it has the potential to build trust by securely storing data in real time.

Data stored within blockchain is auditable, trackable, immutable and can be used to create a longitudinal record of a patient’s health status, for example. With the advantages it brings in terms of security, and the validating nature of the technology, this would benefit every stakeholder – from patients to sponsors.

We’re sure that blockchain will have an increased presence within clinical trials over the coming years.

Translation really is a critical milestone in patient recruitment

Here at COUCH Health, we’re well aware of the importance of translating patient recruitment materials into local languages, be it print or digital. But it was good to hear this talk, by Stéphane Millet, General Manager of Acolad, emphasising the importance of accounting for cultural differences too.

The kinds of things we need to consider when preparing recruitment materials for different countries are:

  • Use of culturally appropriate language – some English words can have negative connotations in other languages and cultures
  • Impersonal language – some words are more impersonal in other languages than English

It’s recommended to do cognitive testing of translated materials with native speakers. This way, you can assess how clear your materials are and if they’re culturally appropriate.

Delivering the best patient experience

Lastly, a talk that really reflected things we stand for at COUCH Health. All about maximising the patient experience. We heard from Zach Hales (Greenphire) and Trishna Bharadia (Health Advocate and Patient Engagement Champion) about how important it is to understand key barriers to participating in trials, including:

  • Being given the opportunity and information
  • Relevance
  • Support – time, financial, logistical
  • Trust

We’ve discussed the importance of considering the participant journey before, and this talk highlighted how this will differ the context of COVID-19 and beyond. Virtual trials or at least elements of virtual trials may come to the forefront faster than they otherwise would’ve done due to the pandemic. Is your study prepared for these changes and ready to decentralise? It’s definitely a movement we’re excited to be a part of!

This blog was first published here.

12th June 2020



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021.
COUCH Health
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs.
COUCH Health
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial is about and to ensure consent is informed. And be something that people are going to remember. And with some trials lasting years, building awareness and familiarity is key to improve engagement. That’s where your clinical trial branding comes in…
COUCH Health
October 2020: diversity and inclusion in clinical trials round-up
In our latest round-up of news surrounding diversity and inclusion in clinical trials, we take a closer look into the benefits that diversity can bring to society, learnings that we can take from the COVID-19 pandemic to shift our thinking around diversity and clinical trials, how we can address long-standing barriers to build trust in healthcare, and much more.
COUCH Health
Live panel discussion: Should diverse representation in UK clinical trials be mandatory?
This online event is being held by Innovative Trials, COUCH Health, and Egality Health.  Three organisations who are working to improve diversity in clinical trials.
COUCH Health
What are the biggest barriers in patient recruitment?
With the advances that have been made in clinical research, it’s almost hard to believe that the same challenges still exist within patient recruitment. Unfortunately, traditional clinical research models pose challenges at many levels and ultimately hinder the efficient running of clinical trials.
COUCH Health